Australia markets open in 37 minutes

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.9500+0.0800 (+1.64%)
At close: 04:00PM EST
4.9500 0.00 (0.00%)
After hours: 05:17PM EST
Full screen
Trade prices are not sourced from all markets
Previous close4.8700
Open4.8200
Bid4.9400 x 4000
Ask4.9600 x 3200
Day's range4.7900 - 4.9600
52-week range3.8700 - 8.6300
Volume2,201,828
Avg. volume1,564,295
Market cap1.449B
Beta (5Y monthly)0.37
PE ratio (TTM)N/A
EPS (TTM)-0.5100
Earnings date02 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.38
  • Business Wire

    AbCellera Announces Resignation of Board Member

    VANCOUVER, British Columbia, February 23, 2024--AbCellera (Nasdaq: ABCL) today announced that Peter Thiel has notified the Company of his intention to resign from the Company’s Board of Directors for personal reasons, effective March 7, 2024.

  • Business Wire

    AbCellera to Present at Upcoming Investor Conferences in March

    VANCOUVER, British Columbia, February 23, 2024--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences:

  • Insider Monkey

    AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript

    AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript February 20, 2024 AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. […]